|1.||Staessen, J A: 8 articles (12/2004 - 01/2000)|
|2.||Birkenhäger, W H: 4 articles (12/2004 - 07/2000)|
|3.||Thijs, L: 4 articles (07/2003 - 03/2001)|
|4.||Wang, J G: 4 articles (12/2001 - 01/2000)|
|5.||de la Sierra, Alejandro: 3 articles (06/2009 - 01/2006)|
|6.||Seux, M L: 3 articles (01/2003 - 07/2000)|
|7.||Forette, F: 3 articles (01/2003 - 07/2000)|
|8.||Kuwahara, Koichiro: 2 articles (10/2014 - 09/2009)|
|9.||Yasuno, Shinji: 2 articles (10/2014 - 09/2009)|
|10.||Nakagawa, Yasuaki: 2 articles (10/2014 - 09/2009)|
|1.||Hypertension (High Blood Pressure)
05/01/1985 - "Thus, nitrendipine appears to be highly effective in reversing ANG II-induced hypertension and Na+ retention. "
03/04/1999 - "Nitrendipine-based antihypertensive therapy is particularly beneficial in older patients with diabetes and isolated systolic hypertension. "
01/01/1992 - "Nitrendipine has been shown to have a high therapeutic efficacy and biochemical tolerance for first-line treatment of elderly patients with mild-to-moderate essential hypertension with or without associated diseases."
12/01/1986 - "These data suggest that nitrendipine is effective in lowering blood pressure, but this is not associated with a significant decrease in LV mass in patients with mild hypertension."
01/01/1984 - "Thirty-seven white patients of both sexes were studied to determine the efficacy and tolerance of nitrendipine for long ambulatory treatment in patients suffering from mild to moderate essential arterial hypertension whose response to the drug had been effective in a previous study. "
09/01/1997 - "The number of L-type Ca2+ channels, measured by nitrendipine binding, was reduced by 21% after 60 min of ischemia. "
02/01/1992 - "Nitrendipine slightly attenuated ischemia/reperfusion-induced decrease in AF. "
01/01/1991 - "The duration of ischemia (37 +/- 43 vs. 5 +/- 9 min, p less than 0.05) as well as the AUC (41 +/- 45 vs. 7 +/- 14 mm/min, p less than 0.05) were reduced only by nitrendipine. "
01/13/1984 - "The beneficial effects for nitrendipine in hemorrhagic shock are likely due to both its vasodilator function and its ability to reduce intracellular Ca2+ accumulation during ischemia, thereby reducing disruption of cell membrane systems."
11/01/1994 - "Group II (n = 6) received SOD 7.0 mg/kg. Group III (n = 6) received nitrendipine 1 mg/kg. Group IV (n = 6) received nitrendipine 1 mg/kg and SOD 7 mg/kg. After administration, both kidneys were rendered ischemic by cross-clamping the renal vessels for 60 min. Comparison of 24-h creatinine clearance (CCr) for 3 days after reversal of ischemia revealed: (a) nitrendipine alone was the most effective in preserving renal function (p < .05); (b) SOD provided some degree of improvement, but only on day 3 (p < .05); (c) a similar result was detected using a combination of nitrendipine and SOD (p < .05); (d) there was no significant difference between SOD and nitrendipine nor between SOD and the combination of nitrendipine/SOD; (e) there was a significant improvement with nitrendipine when compared to the combination of nitrendipine/SOD (p < .05)."
07/01/2003 - "Therefore, nitrendipine as a first line treatment, reduces significantly cardiovascular events, strokes and cardiac events (p = 0.02; p = 0.007; p = 0.009; p = 0.04, respectively) in the diabetic group versus the no diabetic group, with a big trend (p = 0.07) for total mortality. "
03/01/2007 - "Morbidity and mortality after stroke--eposartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES)."
04/01/2010 - "Over the whole duration of follow-up, combination therapy (n = 871), compared with nitrendipine monotherapy (n = 1552), decreased systolic BP by 3.1 mmHg and reduced total mortality (-32%; P = 0.023), with similar trends for all cardiovascular events (-23%; P = 0.081) and stroke (-42%; P = 0.054). "
01/01/1994 - "Effect of nitrendipine on autoregulation of perfusion in the cortex and papilla of kidneys from Wistar and stroke prone spontaneously hypertensive rats."
02/01/1992 - "Nitrendipine may protect hypertensive patients from ischemic stroke onset."
05/01/2003 - "In addition, nitrendipine-based blood pressure-lowering therapy decreased the incidence of dementia. "
07/01/2015 - "Nitrendipine was associated with a reduction in incident dementia in the SYST-EUR trial. "
11/01/2014 - "Prevention of dementia has been reported in hypertensive patients treated with nitrendipine, opening a way for further studies on CCBs' beneficial effect in cognitive deterioration associated with aging. "
07/01/2015 - "At present there is limited evidence to suggest that nitrendipine may be associated with reduction in incident dementia. "
08/01/1999 - "In older people with isolated systolic hypertension, antihypertensive treatment started with nitrendipine may reduce the incidence of dementia. "
01/01/1994 - "Increase of glomerular filtration rate, diuresis, and albuminuria was reversible after withdrawal of nitrendipine. "
01/01/1994 - "Nitrendipine alone did not reduce blood pressure but significantly increased albuminuria, diuresis, glomerular filtration rate, and glomerular volume and injury compared with untreated hypertensive controls. "
08/01/1992 - "In contrast, in the nitrendipine-treated group albuminuria increased from 12.8 +/- 2 progressively to 163 +/- 55 compared with 19.2 +/- 9 mg/24 hr in the hypertensive controls. "
12/01/1990 - "During nitrendipine, albuminuria was slightly higher than during placebo: 0.86 +/- 0.39 vs. 0.58 +/- 0.25 mg/min (NS). "
01/01/1994 - "The combination of nitrendipine and enalapril reduced blood pressure to normotensive levels and not only prevented the increase of glomerular volume, glomerular filtration rate, diuresis, and albuminuria caused by nitrendipine alone but furthermore improved glomerular injury and albuminuria to levels not significantly different from normotensive controls. "
|1.||Calcium Channels (Calcium Channel)
|4.||Surgical Instruments (Clip)
|5.||Renal Dialysis (Hemodialysis)